EMEA-001144-PIP01-11 - paediatric investigation plan

Ulimorelin

Key facts

• Active Substance:
  Ulimorelin
• Therapeutic area:
  Gastroentology-Hepatology
• Decision number:
  P/0129/2012
• PIP number:
  EMEA-001144-PIP01-11
• Pharmaceutical form(s):
  Concentrate for solution for infusion
• Condition(s) / indication(s):
  Prevention of post-operative ileus
• Route(s) of administration:
  Intravenous use
• Contact for public enquiries:

  Norgine Ltd

  United Kingdom; [e-mail] ; [phone]

• Decision type:
  P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
• Decision date:
  04/07/2012

Decision

P/0129/2012: EMA decision of 4 July 2012 on the agreement of a paediatric investigation plan and on the granting of a deferral and on the granting of a waiver for ulimorelin (EMEA-001144-PIP01-11)

AdoptedReference Number: EMA/414917/2012